Homeopathy in the prevention of upper respiration tract infections in children by Steinsbekk, Aslak
Homeopathy
in the prevention of
upper respiratory tract
infections in children
Doctoral thesis
for the degree of Philosophiae Doctor
Program of Clinical Medicine
Trondheim, february 2005
NTNU 
Norwegian University of Science and Technology
Faculty of Medicine 
Department of Public Health and General Practice
Aslak Steinsbekk
Publication from the Norwegian University of Science 
and Technology
Faculty of medicine
Department of Public Health and General Practice
N-7489 Trondheim, Norway
© Aslak Steinsbekk
ISBN 82-471-6951-7 (printed version)
ISBN 82-471-6950-9 (electronic version)
ISSN 1503 3465 Series no. 2005:42
Thesis no. 251 from the Faculty of Medicine
Printed: NTNU-trykk, Dragvoll
N-7491 Trondheim
Tel.: +47-73 59 66 53 or 54
2
Contents
Acknowledgements 5
Abbreviations and definitions 6
Purpose of the thesis 7
The homeopathic context ....................................................... 8
The thesis at a glance 9
What is known ....................................................................... 9
What does this thesis add ...................................................... 10
List of papers 11
General introduction 12
Overview of homeopathy in Norway .................................... 12
The use of homeopathy in Norway ............................... 13
Who visits homeopaths in Norway? ............................. 14
Research on homeopathy in Norway ............................ 15
What is homeopathy? ........................................................... 17
Homeopathic medicines ................................................ 18
Overview of homeopathic research ...................................... 19
Description .................................................................... 21
Safety/adverse effects .................................................... 22
Effectiveness of homeopathic care ................................ 23
Component effect .......................................................... 24
Mechanism of action ..................................................... 25
The methodological quality of homeopathic clinical trials .. 28
Upper respiratory tract infections ......................................... 30
Homeopathic treatment of URTI .......................................... 31
3
Operational aims of the study 33
The original papers
General discussion 34
Methodological considerations of the intervention trials...... 34
Recruitment and trial periods ........................................ 34
Characteristics of the participants/generalisability ....... 34
Withdrawal after randomisation but before start 
of the study .................................................................... 36
Replacement of missing data for those
starting the study ........................................................... 37
Diagnostics of URTI ...................................................... 37
Outcome measurement .................................................. 38
The homeopathic intervention ....................................... 39
Discussion of results ............................................................. 40
Why do parents take their children to homeopaths? ..... 40
Effectiveness of homeopathic care on children 
with URTI ...................................................................... 41
Efficacy of homeopathic medicines on children 
with URTI ...................................................................... 42
A scenario ...................................................................... 43
Perspectives for the future .................................................... 43
Summary in Norwegian 46
Summary in English 48
References 50
4
Acknowledgements
I would like to thank my supervisor Niels Bentzen, who despite his
scepsis regarding the effect of ultramolecular homeopathic medi-
cines, has supplied loads of “good chemistry” and support for the
last three years.
Vinjar Fønnebø has given me excellent support from the first time
he became my supervisor on a documentation project in 1995.
I would also like to thank George Lewith for the invitation to work
at the University of Southampton, for his excellent advice on how
to divide my work and for promptly feedback at all times. 
Sarah Brien and the other colleagues at the Complementary group
at the University of Southampton met me with friendship and
humour. Thanks for work and fun during my stay in Southampton
from august -03 to february -04.
I am also grateful for the cooperation of the participating home-
opaths in this study: Hilde Moldestad, Jan Evenhus, Marit Vaagan,
Siri Tilset and Marit By Rise, and the parents and children who
took part.
Homeoden - Torleiv Holst - provided the homeopathic medicines
during this study and Norges Forskningsråd funded this project.
Without this financial support this project would have been impos-
sible. Thank you!
To my colleagues at Institutt for Public Health and General
Practice I would like to say thanks for nice (and sometimes long)
lunches, which dragged me out of my solitary work, and for funny
and interesting discussions.
I would also like to thank my parents Laila and Jan for continuos
love, interest and support and for making me believe I could
achieve anything.
To my wife Marit and my children, Gabriel and Amalie, I would
like to say thank you for support, humour and love. My life would
be terribly sad and boring without you!
5
Abbreviations and definitions
CAM Complementary and alternative medicine
CI Confidence interval
OTC Over the counter (e.g. medicines bought for 
self-treatment)
RCT Randomised controlled trial
SD Standard deviation
URTI Upper respiratory tract infections
Conventional medicine: The prevailing practice of contemporary
western medicine.
Effectiveness: A measure of the extent to which a health care
intervention fulfils its objectives.
Efficacy: A measure of to which extent a specific intervention pro-
duces a beneficial result under ideal conditions. Ideally, efficacy is
based on the result of a randomised controlled trial.
Ultramolecular: Diluted to an extent where there theoretically is
very unlikely that any molecules are left of the original substance.
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Purpose of the thesis
The research presented in this thesis, has two fundaments:
1. The findings in a survey of 1097 patients visiting 80 different 
homeopaths in Norway (Steinsbekk 2003). The survey revealed 
that it had been a nearly threefold increase in the proportion of 
children among patients visiting homeopaths over 15 years. It 
also revealed that the most frequent reason for encounter among
these children were respiratory and skin problems. 
2. The need for research based on the “real world” use of 
homeopathy that (Linde 1997); 
a. increases the knowledge about those patients that actually 
visits homeopaths and 
b. investigates the effectiveness1 of homeopathic care and 
efficacy2 of homeopathic medicine for conditions and patient
groups that frequently are treated by homeopaths. 
The main research questions therefore became:
- Why do parents take their children to homeopaths?
- What is the effectiveness of homeopathic care in prevention 
of upper respiratory tract infections in children?
- What is the efficacy of self-treatment with self-selected 
homeopathic medicines in prevention of upper respiratory 
tract infections in children?
The operational aims of the thesis is presented on page 33
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1 Effectiveness is a measure of the extent to which a health care intervention
fulfils its objectives (Last 2001).
2 Efficacy is a measure of to which extent a specific intervention produces a
beneficial result under ideal conditions. Ideally efficacy is based on the result of
a randomised controlled trial (Last 2001).
The homeopathic context
A popular saying is that homeopaths treat the patient, not the dis-
ease. What is meant is that homeopaths use the individual charac-
teristics of the patient in their classification system and in deciding
which homeopathic medicine to prescribe. Because of this, patients
can get different homeopathic medicines when they have the same
health problem (conventional diagnosis). 
This is reflected in two main deviations from what is usually seen
in a “traditional” randomised controlled trial where the aim is to
investigate the efficacy of a specific drug in the treatment of a spe-
cific disease (conventional diagnosis). The deviations are that in
the studies presented in this thesis, there is more than on drug and
more than one diagnosis.
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The thesis at a glance
What is known
- Homeopathy is the most frequently used form of 
complementary and alternative medicine (CAM) in Norway.
- There have been homeopaths practicing in Norway for more 
than 130 years.
- Reason for encounter in homeopathic practice is similar to 
general practice with exception of cardio vascular complaints.
- The proportion of children among patients visiting homeopaths 
in Norway has increased from 10% in 1985 to 26% in 1998.
- There are no studies that has explored why parents take their 
children to homeopaths.
- During the last year, Norwegian children aged four with 
frequent colds and otitis media visited physicians ten times 
more frequently than other children.
- Children with upper respiratory tract infections (URTI) are 
frequent antibiotic users. 
- The most frequent reason for visiting a homeopath in Norway 
among children is skin and respiratory complaints.
- There are very few studies evaluating the effectiveness of 
individualised homeopathic care for URTI in children.
- Homeopathic medicines are bought over the counter for 
self-treatment most frequently for respiratory complaints.
- There are no study on whether patients can select the same 
homeopathic medicine as a trained homeopath would prescribe.
- There is a controversy over whether ultramolecular3
homeopathic medicines can have any effect.
- There are no randomised controlled studies showing a statistical
significant specific efficacy of homeopathic medicine in 
children with URTI, although there is a trend for an effect.
9
3 Ultramolecular means that it is diluted to an extent where there theoretically is
very unlikely that any molecules are left of the original substance (Swayne
2000).
What does this thesis add
- Experiences of conventional medical treatment of the child can 
led the parents to take their child to a homeopath because the 
parents
- do not want to give the medication prescribed by the doctor; 
- they want treatment while waiting for a problem to be 
assessed; 
- they do not want to continue to use the prescribed 
medication; 
- they stop taking conventional medication due to side effects; 
or 
- they are not offered any treatment by the medical doctor. 
- Parents would consult a medical doctor if they felt insecure 
about the health conditions of the child and would visit a 
homeopath when they felt that seriousness of the condition was 
clarified.
- Parents choose homeopathy either because they have been 
recommended it from relatives and friends or because they have
personal experience from using it.
- There are parents who take their child to homeopaths despite 
not understanding or having belief in whether ultramolecular 
homeopathic medicines can have effects.
- By using simplified constitutional indications for the 
homeopathic medicines Calcarea carb, Pulsatilla and Sulphur,
parents were able to choose the same as homeopaths prescribed 
for 55% (95% confidence interval 43%-67%) of the children.
- There was a clinical relevant effect of individualised 
homeopathic care in the prevention of upper respiratory tract 
infections in children.
- There was no effect over placebo of self-treatment with one of 
three self-selected ultramolecular homeopathic medicines for 
prevention of upper respiratory tract infections in children.
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General introduction
Overview of homeopathy in Norway
In 1827 homeopathy was described in the Norwegian medical jour-
nal “Eyr” by one of the central persons of modern medicine in
Norway, Fredrik Holst (Holst 1827). A book in Norwegian on
homeopathy was published by “A Norwegian homeopath” in 1870
(En norsk homeopat 1880) (the reference is the second edition).
Another book was published in 1893 (Ohm 1893) and in the same
decade an international conference on homeopathy was held in
Christiania (now Oslo), the capital of Norway. The association
organising only homeopaths in Norway today, Norwegian
Homeopathic Association (NHL), was established in 1930. 
The first homeopathic school was established in 1975 in Oslo and
the second in 1987 also in Oslo. By spring 2004, nearly 700 stu-
dents have graduated from these schools. None of the schools is
officially accredited. The studies are part time and the duration is
at least five years. This includes both medical and homeopathic
subjects. Norwegians, who wanted to take a homeopathic educa-
tion before the schools were established, had to study abroad. 
Homeopathy is not a part of the official health system and is regu-
lated under the “Law of alternative therapies” (Befring 2004). This
law makes it legal for every citizen to treat patients as long as they
don’t harm them. Anyone can call himself or herself a homeopath
without any control of whether or not they have a training in
homeopathy.
Norwegian Homeopathic Association has nearly 430 members who
all have completed an approved homeopathic education. Nearly ¼
of the members are authorised health personnel as well, mostly
nurses. There are few medical doctors who are fully trained in
homeopathy, and the vast majority of homeopathic prescribing is
by homeopaths who are not medical doctors. Among Norwegian
12
medical doctors, one in five hundred practiced homeopathy in
1993 (Aasland 1997).
The use of homeopathy in Norway
Homeopathy is the most frequently used form of complementary
and alternative medicine (CAM) in Norway (Norges Offentlige
Utredninger 1998). In 1997, thirty-seven percent of the population
over 18 years had been to a homeopath during their lifetime. The
proportion was 33% in 1994 (Opinion 1994). Both these surveys
are cross sectional telephone surveys with 1000 randomly selected
participants who were 18 years and older. 
The national health surveys conducted by Statistics Norway have
included a question on visits to homeopaths. In 1975 one in two
thousand (0,05%) of the Norwegian population had seen a home-
opath during the last 14 days (Statistisk sentralbyrå 1977). This
proportion increased to one in four hundred (0,25%) in 1985
(Statistisk sentralbyrå 1987). More recent figures are not available
for 14-day periods, but almost one in fifty (1,83%) of the
Norwegian population had visited a homeopath during the last 12
months in 1995 (Statistisk sentralbyrå 1997). Due to the different
timeframe in the questions, these figures cannot tell whether there
has been an increase in the proportion of Norwegians who visits a
homeopath. All these studies were carried out through personal
interviews with more than 10.000 people of all age groups.
The proportion of Norwegian medical doctors who had been treat-
ed with homeopathy themselves were four percent in 1993
(Aasland 1997) and seven percent in 1995 (Pedersen 1996).
The most recent survey was done in 2001 and was a cross section-
al telephone survey with 1 000 randomly selected participants who
were 18 years and older (Opinion 2001). They found that seven
percent of the population had used homeopathy (the question this
time was not on visits) during the last twelve months and that 72%
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of the population had at least some confidence in homeopathy. By
comparison a survey published in 1977 found that half of the
Norwegian population had confidence in homeopathy (Bruusgaard
1977).
The total number of users is likely to be higher than the telephone
surveys shows, as the telephone surveys only include those who
were 18 years and older. In a survey from 1985 of patients visiting
homeopaths, 10% of the patients were below the age of 10 (Lærum
1985), and the proportion increased to 26% in 1998 (Steinsbekk
2003).
Who visits homeopaths in Norway?
There have been some studies into the characteristics of patients
visiting homeopaths in Norway (Christie 1991; Lærum 1985;
Røisland 1983; Steinsbekk 2003; Straumsheim 1991; Straumsheim
1992a; Straumsheim 1992b). 
In 1983 a study of 301 patients in a single homeopathic practice in
a small Norwegian town was published as a student thesis
(Røisland 1983). It found that the most frequent reasons for
encounter were muscle/skeleton complaints followed by neurologi-
cal and psychological complaints. Fifty-four percent of the patients
had complaints that had lasted for more than five years. Sixty-four
percent of the patients were women, and children under ten years
of age constituted five percent of the patients. 
A survey from 1985 including 1 070 patients visiting 54 different
homeopaths found that the average patient was a woman in her
thirties with higher education (Lærum 1985). The proportion of
health personnel was higher among the patients than in the popula-
tion. The main reason for encounter was musculoskeletal, diges-
tive, psychological, skin and respiratory complaints. Forty-three
percent of the patients had had their complaints for more than five
years. The main reason for visiting a homeopath was fear of side
effects or no effects from conventional treatment, dissatisfaction
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with conventional treatment or that they had tried “everything
else”. Most of the patients had heard about homeopathy from
friends and relatives.
A survey from 1991 with 13 homeopaths and 431 patients found
that women counted for 71% of all patients and that the proportion
of patients under 10 years of age was 17% (Straumsheim 1992a).
The main reason for encounter was respiratory, skin, psychological
and musculoskeletal complaints. This study also included an evalu-
ation of the outcome (Straumsheim 1992b) and it was preceded by
a smaller study with 200 patients (Straumsheim 1991).
A book published in 1991 was based on several studies describing
CAM users and most of these patients had visited homeopaths
(Christie 1991). There were more females than males, the patients
more frequently had higher education but all socioeconomic
groups were represented and nearly all patients had been to a med-
ical doctor before they sought a CAM practitioner. 
The most recent survey was done with 1 097 patients visiting 80
different homeopaths (Steinsbekk 2003). Almost half of the
patients had used prescription drugs provided by a medical doctor
the previous month for the same complaints they presented to the
homeopath. The patients sought homeopathy most often because of
respiratory and skin complaints. Four of the five most common
reasons for encounter in homeopathic practice in 1998 were also
found among the five commonest reasons for consultations in gen-
eral practice (Rokstad 1997). One in four patients visiting home-
opaths in 1998 were children between 0 and 9 years of age.
Research on homeopathy in Norway
The first published study on the clinical effect of homeopathic
treatment in Norway was a pilot study on prevention of lower uri-
nary tract infections (Straumsheim 1990). Subsequently there have
been published articles from randomised controlled trials on indi-
vidualized homeopathic treatment of migraine (Straumsheim
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2000), individualized homeopathic treatment of trauma after tooth
extraction (Lokken 1995), standardized treatment with Arnica for
muscle soreness (Tveiten 1991; Tveiten 1992; Tveiten 1998;
Tveiten 2003) and isopathic4 treatment of birch allergy with home-
opathic medicines made of birch pollen (Aabel 2000b; Aabel
2000a). 
There have also been some homeopathic provings5, one of which
is published internationally (Bruset 1995). There have also been
some master thesis at Norwegian universities focusing on various
aspects of homeopathy (Arnes 1994; Braathen 1998; Evang 2003;
Folden 1997; Heggland 2000; Lunde 1995).
16
4 Isopathy is the use of medicines derived from the causative agent of thee dis-
ease itself, e.g. Pollens to treat hayfever (Swayne 2000).
5 Proving is a trial testing substances on healthy volunteers (Swayne 2000).
What is homeopathy?
Homeopathy is a method of medical practice based on the princi-
ple of similarity (or similia principle, similia similibus curentur).
The hypothesis is that substances capable of causing symptoms in
healthy subjects can be used as medicines to treat people who are
ill with similar patterns of symptoms. 
Although Hippocrates and others have written about the idea of
curing ‘like with like’, it was formally systematised by the German
physician Samuel Hahnemann (1755-1843). The story is that
Hahnemann translated an herbal text from English to German,
which said that Cinochona bark (China officinalis) cured malaria
because it was bitter. He decided to try this himself, and took
repeated doses. He experienced symptoms similar to malaria and
hypothesised the similia principle based on this.
One example of the similia principle is the reactions usually seen
when peeling an onion: It causes tears and burning sensations in
the eyes. This is similar to symptoms of hayfever, and based on the
similia principle a homeopathic medicine made from onion is con-
sidered by the homeopath for patients with hayfever. A similar
example from conventional medicine is to desensitise patients
against the allergen they react to by injecting small doses of the
same allergen. Vaccination is also used as an exemplification of the
similia principle.
To explore the effect different substances have on humans, and
thereby find their indications, homeopaths have done so-called
provings continually for 200 years. In a proving a substance is
administered to healthy persons and all reactions, both physical
and psychological are recorded carefully. This information is found
in homeopathic materia medicas, which are collections of the total
sum of symptoms different substances have provoked in humans.
The homeopathic practitioner should ideally match the complete
status of symptoms of a patient with the recorded symptoms in the
material medica for over two thousand different homeopathic med-
icines.
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The vital force or life force is a central feature of homeopathy
(Bell 2004a). It is a metaphysical concept of the energy that ani-
mates (breaths life into) the organism, but in homeopathy it is seen
as the self-regulating properties of the body. Homeopathic medi-
cines are believed to induce a process of reorganisation of func-
tions by stimulating the self-regulating properties of the body (Bell
2004a). 
Hahnemann held that in principle, the real cause of a disease could
not be explained in total. This was due to the intricate mechanisms
of action together with the activity of the regulating properties of
the body (Hahnemann 1978) (paragraph 6 and 7). Therefore, his
view was to take the symptoms and signs of the disease as they
appear in the patient and treat the patients according to this by
applying the similia principle. Homeopaths pay most attention to
the symptoms that is not typical for the disease as such, but rather
to the symptoms that are unique for the patient. This explains why
homeopaths emphasise the individual features of the patient and
not the conventional diagnosis.
Homeopathic medicines
Homeopathic medicines, in the European Union legally called
“homeopathic medicinal products”, consist of medicines with a
botanical, chemical, mineral, or zoological origin. Original sub-
stances have undergone a homeopathic manufacturing process
called potentisation which is a process of serial dilution and suc-
cussion6 (Schmidt 2003). Homeopathic medicines are used in both
dilutions where there still are traces of the original substances, and
in dilutions where there theoretically is very unlikely that any mol-
ecules are left of the original substance.
Avogadros number (6.023 x 1023) gives the theoretical limit for
when there no longer is any molecule left of the original substance.
Homeopathic medicines that during the manufacturing process are
diluted beyond this limit are termed ultramolecular.
18
6 Succusion is vigorous shaking with impact or ”elastic collision” (Swayne
2000).
Overview of homeopathic research
The following chapter is an overview with examples of published
research on homeopathy. It is not a systematic review, but it aims
at giving an overview of the main research that has been carried
out in areas that relates to the areas studied in this thesis. This
structure is based on a strategy for research development proposed
by the National Research Centre on Complementary and
Alternative Medicine (NAFKAM) at the University of Tromsø,
Norway (Fønnebø 2003).
The choice of research method is dependent on the question for
which an answer is sought. The type of question will vary accord-
ing to ones place in society: 
- From a governmental/regulatory view, it is of interest to know to
what extent the therapy is used in society (Giannelli 2004) and the
likelihood of patients being harmed by using it. In other words, a
request for a description of the use of the therapy and the safety
aspects.
- For the patients the central question is if the therapy, as it is given
in real life, is helping the patient to recover health or reduce symp-
toms. The focus is on the everyday effectiveness of the therapy.
- The scientific communities want to understand which part of the
therapy that has an effect and what the mechanisms of action are. 
Table 1 presents these questions with examples of research meth-
ods that can be used to answer them. 
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Table 1. Strategy for research development with examples of
research questions and methodology.
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Question Research method
Description
What is the prevalence of use
of the treatment? Who uses the
treatment, why and for which
conditions? What are the costs?
Descriptive 
studies. Cross 
sectional surveys.
Qualitative studies.
Safety Is the treatment as it is delivered safe for the patients?
Surveillance.
Cohort. Case con-
trol. Observational
studies
System-/
treatment
effective-
ness
How do the patients experience
the effect of the treatment as it
is given in everyday practice?
What is the effectiveness of 
the treatment compared to 
conventional care for a group
of patients.
Outcome/observa-
tional/ documenta-
tion studies.
Pragmatic rando-
mised clinical 
trials. Controlled
clinical trials.
Component
efficacy
What is the effect of the 
intervention? The intervention
can e.g. be the medicine or the
consultation 
Randomised 
clinical trials.
Meta analysis.
Mechanism
of action
What are the biological/-
physical mechanisms?
Basic research.
Laboratory
research.
Description: The use of homeopathy in the Western
World
Homeopathy is one of the most commonly used form of CAM in
the Western World (Harris 2000). In the European Union, three out
of four citizens know about homeopathy and of these 29% use it
for their own health care (Commission of the European
Communities 1997). The figures are lower in USA (Eisenberg
1998), and the number vary between the Nordic countries with the
lowest number of users in Denmark (Launsø 1996). 
The characteristics of patients visiting homeopathic practitioners
are described in multi centre studies done in different countries
(Anelli 2002; Becker-Witt 2004; Goldstein 1998; Jacobs 1998;
Jansen 1995; Lee 2000; Swayne 1989; Trichard 2003b; Van
Wassenhoven 2004). There are also some studies from single prac-
tices (Colin 2000; Jain 2003; Neville-Smith 1999; Sevar 2000;
Slade 2004; Treuherz 2000; Ward 1995), and from homeopathic
hospitals (Clover 2000; Richardson 2001). The main features are
that most of the users are females (typically 65%-70% of all
patients) and patients who suffer from chronic complaints. Most
patients have tried conventional treatment before they consult the
homeopath. The main reason for encounter is respiratory, psycho-
logical, skin and neurological complaints.
Homeopathic medicines are, in some countries, frequently bought
over the counter (OTC) for self-treatment (Borneman 2001;
Eisenberg 1998; Kayne 1999; Reid 2002; Thomas 2001). In
England 1,2% of the population had visited a homeopathic practi-
tioner during the last year in 1998 and 8,6% of the population had
used homeopathic OTC medicines (Thomas 2001). In 1997, 3,4%
of the population in USA had used homeopathy during the last
year (Eisenberg 1998). Of these, 17% had been to a homeopathic
practitioner. 
The proportion of children among patients visiting homeopathic
practitioners seems to be generally high. In USA in 1992, 24% of
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the patients in homeopathic practice were under 15 years compared
to 17% for conventional medicine (Jacobs 1998). In Netherlands
24% were under 11 years in 1992 (Jansen 1995), in Germany 24%
were under 16 years in 1999 (Becker-Witt 2004) and in France
15% were between 2 and 7 years in 2000 (Trichard 2003b). 
There are no studies exploring why parents take their children to
homeopaths, but there are some surveys on why parents use CAM
for their children (Fong 2002; Loman 2003; Menniti-Ippolito 2002;
Sanders 2003; Spigelblatt 1994). The reasons are word-of-mouth-
recommendations, fear of side effects from drugs, that the child
suffered from chronic medical problems that weren’t improved by
conventional medical treatment, general dissatisfaction with con-
ventional medicine and a more personalised attention in alternative
medicine.
The cost effectiveness of homeopathic care is explored in some
outcome studies where especially the reduction in conventional
drug use is in focus (Becker-Witt 2003a; Frei 2001a; Frenkel 2002;
Guthlin 2004; Jain 2003; Slade 2004; Trichard 2003a; van Haselen
1999; Van Wassenhoven 2004). 
Safety/adverse effects
An international multi centre study of patients visiting homeopathi-
cally trained medical doctors, found that 8% of the patients who
received homeopathic treatment reported adverse effects7 com-
pared to 23% for those receiving conventional treatment (Riley
2001). A German study found that there were more adverse effects
from homeopathic treatment (7%) than from acupuncture (5%)
(Guthlin 2004). 
A feature of homeopathy often mentioned is the initial or therapeu-
22
7 Adverse effect is an undesirable or unwanted consequence of a preventive,
diagnostic or therapeutic procedure (Last 2001).
tic aggravation, which is a temporary worsening of the symptoms
that can occur after the intake of a homeopathic medicine (Swayne
2000). An international multi centre study with 1 025 patients
found that 2.7% of the patients experienced adverse effects, 7.8%
significant aggravation and 25.4% slight aggravation at the begin-
ning of the homeopathic treatment (Anelli 2002). 40% of all
patients in this study remembered to having been informed of the
possibility of an aggravation.
A review of the literature on adverse effects from homeopathic
treatment concluded: “Homeopathic medicines in high dilutions,
prescribed by trained professionals, are probably safe and unlikely
to provoke severe adverse reactions” (Dantas 2000).
Effectiveness of homeopathic care
In all effectiveness studies, there is no way of knowing what con-
stitutes the observed effect, e.g. if it is the intervention or contextu-
al effects. If there are no controls, an observed effect can be due to
improvement over time as well. On the other hand, such studies
can give information about the extent to which a health care inter-
vention fulfils its objectives and is therefore valuable.
There are a number of studies on the effectiveness of homeopathic
care. One type is observational or outcome studies on the effective-
ness of homeopathic care in sub groups of patients. The examples
are homeopathic care for hyperactive children (Frei 2001b),
patients with hot flushes (Clover 2002), patients with atopic and
allergic disorders (Frenkel 2002), male infertility (Gerhar 2002),
patients with headache (Muscari-Tomaioli 2001) and patients with
respiratory complaints (Riley 2001). 
Another type is observational or outcome studies that look at the
overall effectiveness in the whole patient population regardless of
complaint. There are some studies from single practice and hospi-
tals suggesting that 60-80 percent of the patients report an
improvement after homeopathic care (Clover 2000; Richardson
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2001; Sevar 2000; Slade 2004; Treuherz 2000). Two multi centre
studies have found equal results to this (Attena 2000; Van
Wassenhoven 2004).  
Some observational and randomised pragmatic studies have com-
pared homeopathic care to conventional care or treatment for; any
presented complaint (Becker-Witt 2003a), for patients with respira-
tory and ear complaints (Riley 2001) and children with glue ear
(Harrison 1999), recurrent acute rhinopharyngitis (Trichard 2003a)
and otitis media (Friese 1997). These studies have found that
homeopathic care have equal or significant better outcome com-
pared to conventional care. 
Most of these studies are rather simple observational studies with-
out controls. They are all open (not blinded) and they cannot be
used to say anything about a specific effect of homeopathic medi-
cines.
Component effect
Component effect – meta analysis of clinical trials on
homeopathic medicines vs. placebo
The main body of clinical research on the efficacy of homeopathic
medicines has been done in placebo-controlled studies. There have
been two meta analysis pooling studies on heterogenic clinical
conditions and heterogenic homeopathic interventions together to
calculate the overall efficacy of homeopathic medicines compared
to placebo (Cucherat 2000; Linde 1997). Both these meta analysis
have found an effect of homeopathic medicine over placebo, but
this effect is weakened for the best methodological studies. Such
pooling of heterogeneous data has to be treated cautiously, as they
might mask important differences between studies. 
Component effect – laboratory research on homeo-
pathic medicines
There are probably more published papers on laboratory research
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on homeopathic medicines than there are controlled clinical stud-
ies. The Carsten stiftung in Essen, Germany have a database that
now includes over 800 publications that report on over 1 000 dif-
ferent studies (Albrecht 2002).
The only meta analysis in this area was published in 1994 (Linde
1994a). It included 135 studies on the protective effects of what
was called serial agitated dilutions (SADs) of toxin preparations.
They found that the average percent protection of SADs over con-
trols was 19.7 (95%CI 6.2-33.2). Some of the studies meet quality
and comparability criteria for meta-analysis. These were divided
into five comparable groups suitable for meta analysis and four of
these five meta analysis showed significant effects from SAD
preparations over controls.
A systematic review of published experiments on homeopathic
preparations (potencies) that target physical properties found 36
studies (Becker-Witt 2003b). They concluded that most of the stud-
ies had serious methodological flaws, preventing any meaningful
conclusion. 
A laboratory model that study the action of histamine dilutions on
basophil activation have been repeated in some studies and in inde-
pendent laboratories (Belon 2004) and the methodology has been
developed further by others (Lorenz 2003). These studies report
that they have found an effect on basophil activation of histamine
that is homeopathically diluted beyond 10-23 (ultramolecular).
Component effect – reviews of clinical trials on homeopathic
medicines for specific conditions
A comment from the authors of the first large review of clinical tri-
als in homeopathy illustrates a frequent reaction to claims that
homeopathic medicines have an effect (Kleijnen 1991): ”The
amount of positive evidence even among the best studies came as a
surprise to us. Based on this evidence we would readily accept that
homeopathy can be efficacious, if only the mechanism of action
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were more plausible”. They concluded based on a review of 105
studies that “At the moment the evidence of clinical trials is posi-
tive but not sufficient to draw definitive conclusions because most
trials are of low methodological quality and because of the
unknown role of publication bias.”.
A systematic review of systematic reviews of clinical studies in
homeopathy done by the NHS Centre for Reviews and
Disseminations, University of York, UK, found eight such studies
(NHS centre for reviews and disseminations 2002). They conclud-
ed: ”There is currently insufficient evidence of effectiveness to rec-
ommend homeopathy as treatment for any specific condition”.
A critical overview of homeopathy published in 2003 concluded
(Jonas 2003): “There is also evidence from randomized, controlled
trials that homeopathy may be effective for the treatment of
influenza, allergies, postoperative ileus, and childhood diarrhoea.
Evidence suggests that homeopathy is ineffective for migraine,
delayed-onset muscle soreness, and influenza prevention. There is
a lack of conclusive evidence on the effectiveness of homeopathy
for most conditions.”.
All these reviews base their conclusions on including studies with
heterogenic homeopathic interventions together.
Mechanism of action
There is no established model for the mechanism of action of
homeopathy. This concerns both how the similia principle works
and the action of ultramolecular homeopathic medicines. 
It is claimed that the similia principle is used, although not
acknowledged, in conventional medicine (Eskinazi 1999). The arti-
cle gives e.g. examples of conventional drugs where the same dose
can induce opposite effects in different physiologic states (i.e.
digoxin can induce or aggravate arrhythmia as well as control it).
There is a systematic research program on the similia principle
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(van Wijk 1997b). The concepts of self-defence and self-recovery
are central with respect to application of the similia principle in
this research: “At the cellular level, self-defence and recovery
largely depend on the availability of proteins with a cell-protective
function”. They have found that “agents (stressors) which shows a
higher degree of resemblance in cellular response when applied in
high doses also show a higher degree in stimulation of develop-
ment of survival capacity when applied in low doses” (van Wijk
1997a). 
There are a number of theories on the mechanism of action for
ultramolecular homeopathic medicines (Bellavite 2002; Schulte
1998). One often cited is the theory of the “memory of the water”.
Other theories build on complexity theory including non-linearity,
self-organisation and dynamicity (Bellavite 2003; Hyland 2002),
and quantum mechanics and entanglement (Milgrom 2003; Walach
2003). There are also research into possible biomarkers for the
action of ultramoleculare homeopathic medicines in patients (Bell
2004b; Bell 2004c). 
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The methodological quality 
of homeopathic clinical trials
As is evident from the previous overview and the conclusion in
systematic reviews, there have been many studies on homeopathy
with poor methodology (Cucherat 2000; Linde 1997; Mathie
2003). Studies with better methodological quality tend to yield
lower effect size of homeopathic medicines compared to placebo,
but there were no linear relationship between quality and effect
size (Linde 1999). It has been stated that homeopathic research is
clearly in its infancy (Jonas 2001). A guideline for enhancing the
quality of clinical and laboratory homeopathic studies was pub-
lished in 1994 focusing on both methodology and how to describe
the homeopathic intervention (Linde 1994b). 
An investigation of methodological quality of RCTs in CAM found
that homeopathic trials scored better than acupuncture trials and
worse that trials on herbal medicine (Linde 2001). The mean quali-
ty score for the CAM trials were about the same as the score for
two reviews of trials of conventional medicine using the same
methodology to assess the quality (Moher 1996; Moher 1998). For
the trials on homeopathy, less studies were randomised and less
studies had details on dropouts and withdrawals (Linde 2001).
A comprehensive systematic review of the quality of homeopathic
clinical trial was published in 2001 (Jonas 2001). The main prob-
lem areas were found to be with external validity (small sample,
few multi centres). Compared to a sample of high quality conven-
tional clinical trials, the methodological quality of homeopathic tri-
als was not so good, but the internal validity quality score were
similar. 
If a methodological topic was not described in a publication, even
if it was applied in the trial, the quality score would be affected.
Aspects like this might introduce some bias into the nature of the
reported methodological shortcomings. Nevertheless, new clinical
trials on homeopathy have to pay attention to the methodological
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issues raised above. The finding that homeopathic clinical trials
have low sample size and there are few multi centre studies (Jonas
2001), suggest that there is a funding problem as larger multi cen-
tre trials are more expensive. Another aspect is the lack of research
infrastructure. Homeopathy is mainly taught, practiced and
researched outside established institutions like universities,
research centres and national health services. This places a limita-
tion on the available economical resources and the access to highly
qualified and experienced researchers. 
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Upper respiratory tract infections
The term URTI is a separate diagnosis (Wonca International
Classification Committee 1998) while at the same time commonly
being used as a generic name for all infections in ear/nose/throat.
Most upper respiratory tract infections are viral (Wald 1991), and
may lead to complications as otitis media, tonsillitis and sinusitis.
Over 50% of episodes of otitis media occur during an episode of
common cold (Antonia 2002). Based on the result of a pragmatic
randomised controlled trial comparing prescription with antibiotic
to delayed prescription of antibiotics for children with acute otitis
media, it was concluded that for children that are not very unwell
systemically, delayed prescription of antibiotics is acceptable
(Little 2001c). In children with otitis media without fever and/or
vomiting, antibiotic treatment has little benefit on distress and
night disturbance on day three after seeing a medical doctor (Little
2002).
The clinical course of viral URTI is described as lasting more than
seven days for 50% of children (Butler 2003). A quarter of the
children are still ill after ten days. 
A Norwegian population based cross sectional study among four
and five years old children found that nearly half of all children
had two episodes or more of common colds, one in ten had acute
otitis media and 7% tonsillopharyngitis during a twelve months
period (Kvaerner 2000). Another Norwegian population study
found that during the last year, four year old children with URTI
visited physicians ten times more frequently than other children
(Wefring 2001). URTI is the most frequent reason for a drug pre-
scription including antibiotics in general practice in Norway
(Straand 1998).
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Homeopathic treatment of URTI
There have been a number of studies on the effect of homeopathic
care and homeopathic medicines for the treatment of URTI (Linde
1997). Only a few studies have looked at children with URTI. 
A prospective observational outcome study on 230 children with
acute otitis media was performed at a paediatric clinic in
Switzerland (Frei 2001a). 28% of these patients started with antibi-
otics after having been treated homeopathically for 12 hours. The
authors compared their result to that of placebo from another study
and calculated that the individual homeopathic treatment was 2.4
times faster than placebo in controlling pain.
In France, the outcome of homeopathic vs. conventional care for
499 children with rhinopharyngitis (common cold) was investigat-
ed in a prospective non-randomised observational comparison
study only published as conference proceedings (Trichard 2003a).
There were significantly fewer episodes of acute rhinopharyngitis
in the homeopathic care group (2.77 episodes) compared to con-
ventional care (3.83 episodes) during six months. The quality of
life outcome also showed significant results in favour of homeo-
pathic care.
A prospective non-randomised observational study in Germany
compared homeopathic care by a homeopathic ENT specialist (103
children) with conventional care by four conventional ENT spe-
cialists (28 children) for children with acute otitis media (Friese
1997). They found a trend for faster resolution of pain (median 2
vs. 3 days, p=0.119) and fewer recurrences in children (29% vs.
43% with recurrences) in the homeopathic care group. 
In England the effect of homeopathic care and conventional care
for glue ear in 33 children was studied in an open randomised
comparison trial (Harrison 1999). They found that significantly
more children with glue ear progressed to a normal tympanogram
(75% vs. 31%, p=0.015). There was a trend for more children to
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have improved hearing (64% vs. 56%) in the homeopathy group
after one year.
A double blind placebo controlled trial was conducted in the
Netherlands investigating the efficacy of individually prescribed
homeopathic medicines vs. placebo in prevention of URTI in 175
children (de Lange de Klerk 1994). For the main outcome mean
daily symptom score over one year, there was a difference of 0.41
(p=0.06) in favour of homeopathic medicine compared to placebo.
The authors questioned the clinical value of this.
In USA a preliminary double blind placebo controlled trial investi-
gated the efficacy of individually prescribed homeopathic medi-
cines vs. placebo for acute otitis media in 75 children (Jacobs
2001). They found that after five days 19% of those receiving
homeopathic medicines had treatment failure (pain and/or fever)
and 31% in the placebo group (p=0.39). This difference increased
during the next weeks.
Based on this it seems to be an effect of homeopathic care and a
non-significant tendency for a specific effect of homeopathic medi-
cines. However, as the studies are on different conditions, it is not
possible to draw any definite conclusions.
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Operational aims 
of the studies
This thesis is about why parents take their children to homeopaths
and the effect of homeopathic treatment in prevention of upper res-
piratory tract infections (URTI) in children. Four different studies
with the following aims were undertaken:
To explore in depth through qualitative interviews specific issues
as to why parents take their children to homeopaths. (Paper I)
To investigate whether individualised homeopathic care is effective
in the prevention of URTI in children over a 12 week period.
(Paper II)
To develop simplified constitutional indications for three homeo-
pathic medicines to enable parents of children with recurrent
episodes of URTI to choose homeopathic medicine for their child,
and to evaluate if these choices match the prescriptions of trained
homeopaths. (Paper III)
To investigate whether self-treatment with self-selected homeo-
pathic medicines is more efficacious than placebo in preventing
URTI in children over a 12 week period without any interference
by a homeopath. (Paper IV)
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1Paper I
Abstract
Objectives:
To investigate why parents take their children to homeopaths.
Method: 
Purposive sampling to recruit nine parents who had been to a
homeopath with their child for the first time the last three months.
The parents were interviewed in depth using a semi structured
interview guide.
Results:
Experiences with conventional medical treatment of the child led
the parents to take their child to a homeopath: The parents did not
want to give the medication prescribed by the doctor; they wanted
treatment while waiting for a problem to be assessed; they did not
want to continue to use the prescribed medication; they stopped
taking conventional medication due to side effect; or they were not
offered any treatment by the medical doctor. The parents would
consult a medical doctor if they felt insecure about the health con-
ditions of the child and would visit a homeopath when they felt
that situation was clarified.
Conclusion:
Parents in this study would consult a medical doctor before seeing
the homeopath, mainly because they feel uncertain and want a
medical doctor to examine the child. Due to various experiences
with the medical encounter or treatment together with recommen-
dations or personal experience leads the parents to take their child
to a homeopath.
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1Paper II
Summary
Background and objective: Children under ten constitute 26%
of patients visiting homeopaths in Norway. This study investigates
whether individualised treatment by homeopaths is effective in pre-
venting childhood upper respiratory tract infection (URTI).
Design: Open, pragmatic, randomised, parallel group trial with
waiting list group as control.
Patients: 169 children below the age of 10, recruited by post from
children previously diagnosed with URTI.
Interventions: Children were randomly assigned to receive either
pragmatic homeopathic care from one of five homeopaths, or to a
waiting list control using self-selected conventional health care.
Main outcome measure: The outcome relates to the prevention
of new episodes of URTI measured with median total symptom
score over 12 weeks. 
Result: There was a significant difference in the predefined main
outcome in favour of homeopathic care (24, 95% confidence inter-
val 11.4-35.6) compared to the control group (44, CI 32.1-60.8)
(p=0.026). The difference in median number of days with URTI
symptoms was statistically significant with 8 days (CI 4-11.6) in
the homeopathic care group and 13 days (CI 9.1-15) in the control
group (p=0.006). There was no statistical difference in the use of
conventional medication or care between the two groups.
Conclusion: In this study there was a clinical relevant effect of
individualised homeopathic care in the prevention of URTI in chil-
dren. The study gives no data on the specific effect of homeopathic
medicines.
Paper II2
Complementary Therapies in Medicine (2004) 12, 112—117
The use of simpliﬁed constitutional indications for
self-prescription of homeopathic medicine
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Summary
Objectives: To develop simpliﬁed constitutional indications for homeopathic
medicines so that parents of children with recurrent upper respiratory tract infection
(URTI) could choose homeopathic medicines for their children more ‘‘accurately’’,
and to subsequently evaluate if these choices match the prescriptions of trained
homeopaths.
Design and setting: To initially select the most commonly used homeopathic
medicines for URTI, data from a survey of 1097 patients visiting 80 different Norwe-
gian homeopaths were used. A simpliﬁed constitutional indication was then devel-
oped for the three homeopathic medicines most frequently prescribed for recurrent
URTI and otitis media. The constitutional indications were developed by a group
of ﬁve homeopaths and were then sent to 20 homeopaths for further evaluation.
To evaluate the parents’ choice of homeopathic medicines compared to the pre-
scription by trained homeopaths, a group of 11 randomly selected homeopaths were
asked to participate. They recruited parents of 70 child patients.
Result: By using simpliﬁed constitutional indications for the three most commonly
prescribed remedies, Calcarea carb, Pulsatilla and Sulphur, parents were able to
choose the same homeopathic medicine as homeopaths’ prescribed for 55% (95%
CI 43—67) of children with URTI. There was excellent agreement between par-
ents’ choice and homeopaths’ prescription for the three medicines (Kappa of 0.77,
p < 0.001).
Conclusion: Simpliﬁed constitutional indications can be used to improve the quality
of the choice of homeopathic medicines purchased over the counter (OTC) for self-
treatment.
© 2004 Elsevier Ltd. All rights reserved.
 Source of support is Norwegian Research Council.
* Corresponding author. Tel.: +47 73 59 75 74;
fax: +47 73 59 75 30.
E-mail address: aslak.steinsbekk@medisin.ntnu.no
(A. Steinsbekk).
Introduction
Patients can initiate treatment with homeopathic
medicines either by going to a homeopath or by
buying the homeopathic medicine over the counter
0965-2299/$ — see front matter © 2004 Elsevier Ltd. All rights reserved.
doi:10.1016/j.ctim.2004.09.004
DOI:10.1111/j.1365-2125.2005.02336.x
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Aims
 
Homeopathic medicines are frequently purchased over the counter (OTC). Respiratory
complaints are the most frequent reason for such purchases. Children with upper
respiratory tract infection (URTI) are frequent users of homeopathy. This study
investigates the effect of self treatment with one of three self selected ultramolecular
homeopathic medicines for the prevention of childhood URTI.
 
Methods
 
A double-blind randomized parallel group placebo controlled trial was carried out in
251 children below the age of 10 years, recruited by post from those previously
diagnosed with URTI when attending a casualty department. The children were
randomly assigned to receive either placebo or ultramolecular homeopathic medi-
cines in C-30 potency (diluted 10
 
-
 
60
 
) administered twice weekly for 12 weeks. Parents
chose the medicine based on simplified constitutional indications for the three
medicines most frequently prescribed by Norwegian homeopaths for this group of
patients. The main outcome measure relates to the prevention of new episodes of
URTI measured with median total symptom score over 12 weeks.
 
Results
 
There was no difference in the predefined primary outcome between the two groups
(
 
P 
 
=
 
 0.733). Median URTI scores over 12 weeks in the homeopathic medicine group
were 26.0 (95% confidence interval (CI) 16.3, 43.7) and for placebo 25.0 (95% CI
14.2, 38.4). There was no statistical difference between the two groups in median
number of days with URTI symptoms or in the use of conventional medication/care.
 
Conclusions
 
In this study there was no effect over placebo for self treatment with one of three
self selected, ultramolecular homeopathic medicines in preventing childhood URTI.
This can be due to the lack of effect of the highly diluted homeopathic medicines or
the process of selection and type of medicines.
General discussion
Methodological considerations of the inter-
vention trials
The main methodological issues are discussed in the papers, and in
the following, some of these are elaborated upon and given a more
detailed discussion.  
Recruitment and trial periods
The two intervention trials (study II and IV) recruited patients
simultaneously. It was sent invitation to 1 937 patients who had
attended the casualty department at the university hospital in
Trondheim between September 2002 and December 2003. Of
these, 395 (20,5%) returned the signed informed consent form. In
addition, 86 patients were recruited by folders distributed to local
child health centres in November 2002 (n=29) and an advertise-
ment in the local newspaper in January 2004 (n=57). Of these 481
children, 420 returned the baseline questionnaire and were ran-
domised.
The trials took place simultaneously in two periods; September
2002 to June 2003 (n=161) January to June 2004 (n=259). Those
patients attending the casualty department between August 2002
and January 2003 participated in the first part and those participat-
ing in the second part attended the casualty department between
February and December 2003.
Characteristics of the participants/generalisability
An important aspect of the generalisability of the results from the
intervention trials is whether the participants are similar to the pop-
ulation (all children with URTI in Trondheim). The inclusion crite-
ria should ensure the inclusion of children that consult the health
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service for URTI. This group was expected to be the largest group
of children needing medical care, as documented in the Norwegian
population study which showed that during the last year, four year
old children with frequent colds and otitis media visited physicians
ten times more frequent than other children (Wefring 2001).
As a group, the participating children cannot be said to have been
very bothered with URTI. The average child, who was three years
old, had “only” had two ear infections and two throat infections
during his/her lifetime. Among Norwegian four year olds, one in
three have had an episode or more of otitis media and nearly one in
three have had four or more episodes of colds during the last year
(Wefring 2001). The participating children therefore probably
belong to the population of children who have some complaints
but who are not very troubled.
Whether the participants are representative for patients with URTI
visiting homeopaths is another question. There are no data from
homeopathic practice in Norway that can be used to compare the
participants in the trials to the “usual” patients in homeopathic
care. Based on the impression of the homeopaths in the homeo-
pathic care trial, the participants seemed to be less ill and they
failed to attend their scheduled consultations more frequently than
their usual patients do. As a speculation, this could indicate that in
everyday life homeopaths are for the larger part visited by the
more ill children since patients have to pay all expenses them-
selves when they consult a homeopath. In the trials, the costs of
the consultation and the study medication were covered. This was
also emphasised in the recruitment material.
It can be expected that those participating in a homeopathic trial do
so because they are believers in homeopathy/CAM. The parents to
the participating child patients were asked about this in the base-
line questionnaire. Nearly 40% reported to have confidence in
homeopathy, a further 60% were “neutral” and the rest (2.5%) had
no confidence. In 2001 52% of the Norwegian adult population
said that homeopathy should be part of the national health service
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(Opinion 2001). Although these figures are not directly related,
they suggest that the parents of the children in this project did not
differ largely from the adult population with regard to their view
on homeopathy. 
Withdrawal after randomisation but 
before start of the study
If there are many withdrawals, the result of the study might be
compromised if there are more withdrawals in one group as this
might indicate that the withdrawals are treatment related (Altman
1991). Further more the whole study might be compromised as the
whole process of statistical inference from sample to population
fails if the sample is not representative. In high quality clinical tri-
als on homeopathy that has reported on this, the average dropout
rate was 17% (Jonas 2001).
As is evident in the tables with baseline characteristics of the chil-
dren in paper II (table 2) and IV (table 3), the randomisation
ensured a balanced distribution of the participants in the two trials.
In the intervention trials, 84% (142/169, paper II) and 79%
(199/251, paper IV) of those randomised were included in the final
analysis. There was no data on those not analysed as they did not
start the study after randomisation or did not return any data. It
was accounted for the reason for not starting the study for about
half of the patients that were not in the analysis (figure 1 in paper
II and IV). The main reason was practical issues like being to busy
to find time to participate.
The number of patients who did not start in the study was almost
the same in each group, indicating that the results from study II
and IV are valid. Those not starting the study were compared to the
reminders in each groups and there was no significant difference
between them for the baseline characteristics. This indicates that
the sample included in the final analysis is as close to the popula-
tion as the original sample is. 
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Replacement of missing data for those starting the
study
If the number of participants with missing data is small and equal
in each group in a clinical trial, the common approach is to omit all
such patients (Altman 1991). One possible approach to ensure that
this is sensible is to assign the most optimistic and pessimistic out-
come to patients with missing data. If these analyses gives similar
results, and these results are similar to an analysis without those
missing, then the data from those missing can be omitted. 
In the intervention trials it was pre-planned (stated in the protocol)
that missing data should be replaced with the average of the
recorded values carried forward. By doing this, it was found that
the participants with missing data for part of the study tended to do
worse, although not statistically significant, than those without
missing data. As the number of patients with missing data for part
of the studies were comparable (study IV) or higher for the homeo-
pathic care group (study II), there was no reason to change the
planned handling of missing data.
Diagnostics of URTI
It was left to the parents to decide if their child was ill and whether
it involved the ear/nose/throat. This is in line with a homeopathic
approach, but does not facilitate the criteria for a conventional
medical diagnosis. The term URTI might therefore be misleading if
it is looked upon as a single diagnosis (Wonca International
Classification Committee 1998). It might be argued that the most
appropriate term for the condition investigated would be children
with complaints in ear/nose/throat and not URTI. Nevertheless, as
the term URTI is frequently used as a generic name for all
ear/nose/throat infections, the use of the term in this studies seems
appropriate.
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Outcome measurement
Only one measurement approach was used for the outcomes (mono
method bias). It was the parents of the patients that completed the
diaries, meaning that all results are based on self-reporting from
someone other than the patient (proxy). This was intended because
the aim was to measure the effect on how the parents judged the
condition of their child. Due to the prospective design, that the trial
studied the effect on prevention and the definition of URTI used
(see above), it would be of little value to include a before/after
evaluation by an independent observer.
The main outcome measure, the symptom diary used on days when
the parents judged their child to be ill with URTI complaints, could
reach a score on 11 each day. The median scores in the studies
were about 3 for each day when the parents judged their child to be
ill with URTI. The reason for using the symptom score as the main
outcome was that it was expected to give higher variability than
number of days with URTI and thereby be a more sensitive meas-
ure. In a future study with this outcome, it might be considered if a
more detailed scoring could be used, e.g. a four (Jacobs 2000) or
seven (Watson 2001) point Likert scale. This would further
increase the variability and thereby the sensitivity to measure
changes.
It was decided to set the study time to three months after consulta-
tions with other homeopaths as well as for practical purposes. This
could be viewed as too short a period to measure prevention of
URTI. By including children with a URTI diagnosis from a med-
ical doctor, the anticipation was that these would be more prone to
get new episodes of URTI. The sample size was calculated based
on fifteen days with URTI in the untreated group. The median days
with URTI was thirteen and the median number of episodes was
two in the standard care group not receiving any “study” interven-
tion. This indicates that the study time was reasonable, but could in
hindsight have been prolonged to four months. 
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The homeopathic intervention
The homeopathic prescribing is frequently based on the character-
istics of the patients. Therefore the intervention cannot be stan-
dardised as long as the inclusion criteria is a conventional medical
diagnosis. As is evident from study III, it is possible to mirror
homeopaths prescription without involving the homeopath. But as
study II shows, a homeopath would have used many more different
homeopathic medicines in the treatment of this patient group than
the three medicines in study IV. 
The homeopaths prescription in study II differs somewhat from
that of Norwegian homeopath as described in study III. Forty per-
cent of the patients in study II were prescribed Calcarea carb com-
pared to 30% among Norwegian homeopaths. In Study IV 40% of
the parents self-selected this medicine and this proportion would
probably be lower if they had to choose between more homeopath-
ic medicines.
One possible way of conducting a trial so that the homeopathic
medicine can be standardised, is to have an inclusion criteria that
states that only patients matching the indication for a homeopathic
medicine are to be included. This has e.g. been done in a study on
fibromyalgia were only patients matching the homeopathic medi-
cine Rhus tox was included (Fisher 1989). The problem with this
approach is that many patients have to be screened, making the
recruitment job very large and giving the study limited external
validity.
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Discussion of results
Why do parents take their children to homeopaths?
Study I explored why parents take their children to homeopaths. It
was found that they mainly do so after having been to a medical
doctor and not getting the help they wanted. The reasons found for
deciding to go to a homeopath, are mostly similar to the findings in
the surveys of why parents uses CAM for their children (Fong
2002; Loman 2003; Menniti-Ippolito 2002; Sanders 2003;
Spigelblatt 1994). 
Homeopathy seems to be used as a sort of self-selected second line
service. This raises the question of whether there is something that
homeopaths “give” the patients that they do not get in the medical
encounter. Patients request communication, partnership, and health
promotion from general practitioners (Little 2001a; Little 2001b). 
It might be that due to their focus on the patients and not the dis-
ease, homeopaths have a built in advantage with respect to being
patient centred. As long as the focus is on the patient, it is likely
that the patients feel that the homeopath takes an interest. This
leads to the hypothesis that the a priori view on health and disease
might account for the degree of patients centeredness: If one sees
the disease as an entity that lives its’ own life, then the focus
becomes the disease itself. If on the other hand disease is seen as
dependent on the patient and his/hers situation, then the focus
becomes the patient.  
It would be interesting to study which factors in the medical
encounter that might influence whether patients goes on to consult
a homeopath/CAM practitioner or not. This could give data that
indicate areas for improvement in the medical encounter.
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Effectiveness of homeopathic care 
on children with URTI
In study II it was found that there was a significant and relevant
difference in favour of homeopathic care compared to self-selected
standard care in the prevention of URTI in children in a three
month period. This is in line with others pragmatic randomised
(Harrison 1999) and non-randomised/observational studies (Frei
2001a; Friese 1997; Trichard 2003a) on URTI in children. The
clinical conditions and settings vary between all these studies, pre-
venting a direct comparison. 
Although there is very little research, the result suggests that
homeopathic care can be of help for children with both acute and
more chronic URT complaints. It also suggests that homeopathic
care can be used as both a preventive and acute treatment for these
patients.
It is suggested in paper II that the increase in the proportion of
children among patients consulting homeopaths might be due to a
lay knowledge about beneficial effect of homeopathic care. This
suggestion is strengthen by the findings in study I that parents take
their children to homeopaths after recommendations from relatives
and friends or based on having a positive experience themselves.
As already mentioned, studies on effectiveness cannot give infor-
mation about any specific effects. Still patients seem to relay on
this sort of information in deciding which treatment modality to
use (study I). 
In the special case of homeopathy, this is even more intriguing
because of the implausibility of an effect of ultramolecular homeo-
pathic medicines: “The problem with homoeopathy is not that
there is no explanation for its possible action. If there is no expla-
nation for the action of an agent, one might still give it the benefit
of the doubt under certain conditions. The problem with
homoeopathy is that the “infinite dilutions” of the agents used can-
not possibly produce any effect” (Vandenbroucke 1997). There is a
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considerable gap between this view and relying on anecdotic sto-
ries or evidence of effectiveness as patients seems to do. 
Efficacy of homeopathic medicines 
on children with URTI
In study IV there was no statistical significant difference between
self-treatment with self-selected ultramolecular homeopathic medi-
cines compared to placebo. The two other double blind placebo
controlled studies on children with URTI (de Lange de Klerk 1994;
Jacobs 2001), have found a non-significant tendency for a specific
effect of homeopathic medicines. Both these studies used experi-
enced homeopaths to prescribe homeopathic medicines for the
patients. 
Study IV has an innovative design as the intervention mirrors the
prescribing of homeopaths without exposing the patients to a
homeopath. This design should make it possible to reduce the con-
textual influences of the homeopath – patient interaction. This
interaction might raise the non-specific effects and thereby require
larger numbers of study participants to find a specific effect of an
intervention. 
As the post sample-size calculation based on the results from the
sub-analysis shows (see discussion, paper IV), 5 000 participants
would have to be included to find a significant specific effect of
ultramolecular homeopathic medicines using this design. This indi-
cates that if there is a specific effect of ultramolecular homeopathic
medicines, it is little feasible to use this design to investigate it
using children with URTI as subjects. Although it is possible to do
studies of this size, it has never been a homeopathic study that
large (Linde 1997), probably due to economic constraints and a
lack of research infrastructure. 
It is frequently claimed that the effect of ultramolecular homeo-
pathic medicines are equal to placebo (Ernst 2002). The results
from study IV support this claim. 
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A scenario
With the relatively large proportion of children with URTI among
patients consulting homeopaths, there is a need for further studies
investigating both the effectiveness of homeopathic care and the
specific efficacy of homeopathic medicines. Nevertheless, for the
sake of arguments, imagine that homeopathic care is beneficial and
homeopathic medicines equals placebo. What should be the conse-
quences if this scenario was real? Should homeopathic medicines
be banned (or at least the public be advised against visiting home-
opaths) because the medicines is without effect? Or should one
encourage the use of homeopathic care since it is beneficial even
when using medicines that gives no effect over placebo? 
These questions are probably capable of dividing between oppo-
nents and supporters of homeopathy, who will answer according to
their own belief. Nevertheless, what it illustrates is the difficulties
in practical utilisation of scientific evidence. It is sufficient to look
at the long history of reactions against homeopathy from conven-
tional medical bodies (Jonas 2003), to substantiate this. It seems
fair to suggest that the answer to the questions above requires a
political or ideological clarification/solution more than a scientific
one. 
Perspectives for the future
There is still a great need for research into what constitutes, if any,
the effect of homeopathy as such. It is obvious that there are many
aspects that have to be researched, e.g. the effect of the homeo-
pathic medicines, the effect of the interaction between the practi-
tioner and the patients, the effect of having to pay for the service
out of ones own pocket and the effect of longer consultations. One
starting point is to do studies that separate the patient-homeopath
interaction (clinical process) from the specific effects of the home-
opathic medicines (Jonas 2001). This would require trials with sev-
eral arms that make it possible to compare these. A protocol for
such a study with five arms has recently been published (Brien
2004).
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The intervention studies in this thesis are more related than it
appears from what have previously been written. The grand
thought was to design the studies so that it would be possible to
explore the issue of the effect of homeopathic care vs. the effect of
homeopathic medicines. This was done by integrating the separate
investigations (study II and IV) in a four arm design and nearly all
aspects of the trials were equal with exception of the intervention
This design has been published in a separate article (Steinsbekk
2004) and is presented in the figure below. In study II arm 1 and 2
were compared and in study IV arm 3 and 4 were compared.
By the time this thesis was submitted, there had not been time to
start the analysis comparing all four arms. The plan is to start to do
the analysis at the end of 2004/beginning of 2005. This analysis
might for the first time give data on the difference between the
specific effects of the homeopathic medicines and the contextual
effects of the clinical process.
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Randomisation
All parents are asked in the baseline questionnaire to choose 
which one of three descriptions of indications for homeopathic 
medicines that most resembles their child
Group B
Treatment by homeopaths 
who can prescribed any 
homeopathic medicine 
Arm 4
Placebo
Arm 2
Homeopathic
care
Group C
Self treatment with the 
homeopathic medicine 
chosen prior to
randomisation
Randomisation
Arm 3
Homeopathic 
medicine
Group A
Waiting list
who uses
standard care
Arm 1
Standard
care
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Summary in Norwegian 
Hensikten med denne avhandlingen er å undersøke hvorfor forel-
dre tar sine barn med til homøopat og å undersøke effekten av
homøopatisk behandling i forebygging av øvre luftveisinfeksjoner
(ØLI) hos barn. Bakgrunnen for de undersøkelsene som er gjort, er
at det nesten er en tredobling i andelen barn blant pasienter hos
homøopat. Dette utløste spørsmål om hvorfor det er slik. Videre er
gjentatte luftveisplager en hovedårsak til at barn oppsøker homøo-
pat. Fordi det er lite forskning på dette temaet ble spørsmålet om
effekten av homøopatisk behandling i denne pasientgruppen også
utløst. Avhandlingen bygger på fire ulike undersøkelser som er
gjennomført mellom august 2002 og juni 2004.
Foreldre til ni barn som nylig hadde vært hos homøopat for første
gang ble intervjuet for å undersøke hvorfor foreldre tar sine barn
med til homøopat. Alle foreldrene hadde vært hos lege før de kon-
taktet homøopaten, og det var erfaringer med legebehandlingen
som fikk foreldrene til å søke alternativer. Årsakene var at forel-
drene 1) ikke ønsket å gi den behandlingen lege foreskrev til bar-
net, 2) ønsket behandling mens barnet ventet på å bli ferdig utre-
det, 3) ønsket å avslutte bruken av de medisinene legen hadde fore-
skrevet for barnet, 4) opplevde at barnet fikk bivirkninger av
behandlingen legen hadde gitt og 5) ikke ble tilbudt noen behand-
ling hos legen. Foreldre oppsøker først lege når de er usikre eller
bekymret for barnets helsetilstand. De oppsøker homøopat for
behandling når dette er avklart. Det er foreldre som oppsøker
homøopat med sine barn selv om de ikke forstår eller tror på effek-
ten av homøopatiske medisiner (som kan være svært fortynnet).
Ett hundre og sekstini barn som hadde vært til lege på grunn av en
øvre luftveisinfeksjon ble rekruttert til å være med på en undersø-
kelse av effekten av behandling hos homøopat i forebyggingen av
ØLI hos barn. Barna ble tilfeldig fordelt i to grupper. Barna i den
ene gruppen fikk time med en gang hos en av fem homøopater
som foreskrev homøopatisk behandling på vanlig måte. Den andre
gruppen fikk slik behandling etter 3 måneder. Forekomsten av ØLI
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var signifikant lavere hos de som fikk behandling hos homøopat
med én gang (median 8 dager på tre måneder) sammenlignet med
den andre gruppen som brukte standard behandling ved behov
mens de ventet (median 13 dager) (p=0,006).
Homøopatisk medisin brukes internasjonalt i stor grad til selvbe-
handling. Man vet ikke om pasientens eget valg av homøopatisk
medisin er lik det en homøopat ville foreskrevet. Det ble derfor
gjennomført en undersøkelse av om det kan utvikles beskrivelser
for indikasjoner for homøopatiske medisiner som gjør at foreldre
kan velge samme medisin som en homøopat foreskriver for barn
med ØLI. Først ble det funnet fram til tre medisiner, Calcarea
carb, Pulsatilla og Sulphur som homøopater i Norge foreskriver til
60% av barn med ØLI. Så ble det utviklet indikasjoner for disse tre
medisinene som ble testet ut ved at valgene til 70 foreldre ble
sammenlignet med foreskrivingen til 11 homøopater. Foreldrene
valgte samme medisin som homøopaten for 55% av barna.
To hundre og femtien barn som hadde vært til lege på grunn av en
øvre luftveisinfeksjon ble rekruttert til å være med på en undersø-
kelse av effekten av en av tre selvvalgte homøopatiske medisiner i
forebyggingen av ØLI hos barn. Indikasjonene som ble utviklet ble
brukt. Barna ble tilfeldig fordelt til enten å få homøopatisk medisin
eller placebo. Det var ingen signifikant forskjell i forekomsten av
ØLI mellom de som fikk homøopatisk medisin sammenlignet med
de som fikk placebo (median 9 dager på tre måneder i begge grup-
per) (p=0,531).
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Summary in English
The aim of this thesis is to explore why parents bring their children
to homeopaths and to investigate the effect of homeopathic treat-
ment for prevention of upper respiratory tract infections (URTI) in
children. The reason for doing studies on this is that there has been
a nearly threefold increase in the proportion of children among
patients visiting Norwegian homeopaths. This raised the question
of why it is so. Furthermore, recurrent respiratory complaints are a
main reason why child patients consult homeopaths. This raised
the question of the effect of homeopathic treatment in this patient
group, because there is very little research on this. The thesis
builds on four different studies conducted between August 2002
and June 2004.
Parents of nine children that recently had been to a homeopath for
the first time were interviewed to explore why parents take their
children to homeopaths. All parents had been to a medical doctor
before consulting the homeopath. It was the experiences with con-
ventional medical treatment that led the parents to look for alterna-
tives. The reasons were that 1) the parents did not want to give the
medication prescribed by the doctor, 2) they wanted treatment
while waiting for a problem to be assessed, 3) they did not want to
continue to use the prescribed medication, 4) they stopped taking
conventional medication due to side effects or 5) they were not
offered any treatment by the medical doctor. The parents would
consult a medical doctor if they felt insecure about the health con-
ditions of the child and would visit a homeopath when they felt
that the situation was clarified. There are parents who take their
child to homeopaths despite not understanding or having belief in
whether ultramolecular homeopathic medicines can have effects.
One hundred and sixty-one children who had been diagnosed with
an URTI by a medical doctor were recruited to participate in a trial
on the effect of treatment by homeopaths for prevention of URTI
in children. The children were randomly allocated to two groups.
One group received an appointment immediately with one of five
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homeopaths who treated the patients as they do in their everyday
practice. The other group (control) got such treatment after three
months. The occurrence of URTI judged by the parents were sig-
nificantly lower among those treated immediately by homeopaths
(median 8 days in three months) compared to the control group
who used self-selected conventional health care (median 13 days)
(p=0.006). 
Homeopathic medicines are frequently used for self-treatment
(over the counter-OTC). It is not known if the choice of the patient
is the same, as a homeopath would have prescribed.  A study was
therefore conducted to explore if there can be developed indica-
tions for homeopathic medicines that facilitate that parents can
chose the same medicine as a homeopath would prescribe for chil-
dren with URTI. Firstly, data from a survey was used to find three
medicines Calcarea carb, Pulsatilla and Sulphur that accounted
for 60% of all prescription made by Norwegian homeopaths for
children with URTI. Simplified constitutional indications for these
medicines were developed and tested  by comparing the choices of
70 parents with the prescription of eleven homeopaths. The parents
were able to choose the same homeopathic medicine as home-
opaths prescribed for 55% of the children.
Two hundred and fifty-nine children who had been diagnosed with
an URTI by a medical doctor were recruited to participate in a trial
on the effect of one of three self-selected ultramolecular homeo-
pathic medicines for prevention of URTI in children. The indica-
tions developed were used. The children was randomly allocated to
receive either ultramolecular homeopathic medicine (C-30) or
placebo. There was no difference in the occurrence of URTI judged
by the parents among getting ultramolecular homeopathic medicine
compared to those getting placebo (median 9 days in three months
for both groups) (p=0.531). 
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